HomeSCPI • IDX
add
Organon Pharma Indonesia Tbk PT
Market news
Financials
Income Statement
Revenue
Net income
| (IDR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 904.53B | -10.14% |
Operating expense | 18.62B | 66.01% |
Net income | 68.37B | -46.08% |
Net profit margin | 7.56 | -40.00% |
Earnings per share | — | — |
EBITDA | 93.70B | -45.15% |
Effective tax rate | 23.63% | — |
Balance Sheet
Total assets
Total liabilities
| (IDR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.17B | -39.25% |
Total assets | 1.74T | 12.70% |
Total liabilities | 717.03B | 51.00% |
Total equity | 1.02T | — |
Shares outstanding | 3.60M | — |
Price to book | 0.10 | — |
Return on assets | 12.84% | — |
Return on capital | 22.03% | — |
Cash Flow
Net change in cash
| (IDR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 68.37B | -46.08% |
Cash from operations | 19.27B | -77.73% |
Cash from investing | -20.53B | -540.21% |
Cash from financing | -751.14M | 99.58% |
Net change in cash | -1.88B | 98.02% |
Free cash flow | -48.52B | 60.01% |
About
Founded
1972
Website
Employees
187
